Micro-k and Neuralgia - a phase IV clinical study of FDA data

Summary:

Neuralgia is reported as a side effect among people who take Micro-k (potassium chloride), especially for people who are female, 50-59 old, also take Glucophage, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Neuralgia when taking Micro-k. It is created by eHealthMe based on reports of 1,874 people who have side effects when taking Micro-k from the FDA, and is updated regularly.

What is Micro-k?

Micro-k has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 1,895 Micro-k users. Check the latest studies of Micro-k.

What is Neuralgia?

Neuralgia (pain in one or more nerves) is found to be associated with 1,389 drugs and 1,789 conditions by eHealthMe. Check the latest studies of Neuralgia.

On Jul, 17, 2026

1,874 people reported to have side effects when taking Micro-k.
Among them, 17 people (0.91%) have Neuralgia.

Among these 17 people:

What is the gender of people who have Neuralgia when taking Micro-k? *

female: 52.94 %
male: 47.06 %

What is the age of people who have Neuralgia when taking Micro-k? *

What are other drugs people take besides Micro-k? *

What are other side effects people have besides Neuralgia? *

Joint Pain: 11 people, 64.71%
Pain: 10 people, 58.82%
Stress And Anxiety: 10 people, 58.82%
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle): 9 people, 52.94%
Osteonecrosis Of Jaw (death of bone of jaw): 9 people, 52.94%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 9 people, 52.94%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 9 people, 52.94%
Myelitis Transverse (a neurological condition consisting of an inflammatory process of the spinal cord): 9 people, 52.94%
Mucosal Inflammation (infection of mucous membrane): 9 people, 52.94%
Light Chain Analysis Increased: 9 people, 52.94%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 9 people, 52.94%
Pain: 7 people, 41.18%
Insomnia (sleeplessness): 7 people, 41.18%
Muscle Spasms (muscle contraction): 6 people, 35.29%
Intervertebral Disc Degeneration (spinal disc degeneration): 4 people, 23.53%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 2 people, 11.76%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 11.76%
Type 2 Diabetes: 2 people, 11.76%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 5.88%
Axonal Neuropathy (dysfunction of axon nerves): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Micro-k and have Neuralgia?

- Check whether Neuralgia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Micro-k:

Micro-k (1,895 reports)

Neuralgia treatments and more:

Neuralgia (81,600 reports)

Browse all side effects of Micro-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neuralgia:

Neuralgia (1,389 drugs)

Browse all the conditions that are associated with Neuralgia:

Neuralgia (1,789 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride (the active ingredients of Micro-k) and Micro-k (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.